These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1606342)

  • 1. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Urtasun M; López de Munain A; Carrera N; Martí-Massó JF; López de Dicastillo G; Mozo C
    Ann Pharmacother; 1992 Jan; 26(1):32-3. PubMed ID: 1606342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
    Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
    Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome].
    Hidou M; Olivier J; Vivant JF
    Rev Neurol (Paris); 1992; 148(11):706-8. PubMed ID: 1303562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Guillain-Barré syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India.
    Kishore CK; Vijayabhaskar J; Vishnu Vardhan R; Sainaresh VV; Sriramnaveen P; Sridhar AV; Varalaxmi B; Sandeep P; Ram R; Vengamma B; Siva Kumar V
    Ren Fail; 2014 Jun; 36(5):732-6. PubMed ID: 24593239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome in a 93-year-old woman: rapid improvement of neurologic function following intravenous immunoglobulin.
    Uldry PA; Bogousslavsky J; Regli F
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(4):301-5. PubMed ID: 1719624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of Guillain-Barré syndrome].
    Zagar M
    Lijec Vjesn; 1995; 117(9-10):246-9. PubMed ID: 8643018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guillain-Barré syndrome treated with high doses of immunoglobulins by the intravenous route: 4 cases].
    Uldry PA; Bogousslavsky J; Regli F
    Rev Neurol (Paris); 1991; 147(8-9):573-6. PubMed ID: 1962066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
    Kamei T; Nakagawa H; Uchiyama F; Fukuyama J
    Rinsho Shinkeigaku; 1993 Jun; 33(6):660-2. PubMed ID: 8403689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasmapheresis and high-dose immunoglobulins in the treatment of acute demyelinating polyneuropathy].
    Marino A; Logi G; Roncucci P; Sodini ML; Fornaini F
    Minerva Anestesiol; 1993 Jun; 59(6):307-11. PubMed ID: 8414090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The place of high dose immunoglobulins in the treatment of Guillain-Barré patients based upon the dutch trial.
    van der Meché FG
    Wien Klin Wochenschr Suppl; 1991; 190():17-8. PubMed ID: 1771902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.
    Oczko-Walker M; Manousakis G; Wang S; Malter JS; Waclawik AJ
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):55-61. PubMed ID: 21386771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of immunomodulation therapies in mechanically ventilated patients with Guillain Barré syndrome.
    Netto AB; Kulkarni GB; Taly AB; Rao GU; Periyavan S; Rao S
    J Clin Neurosci; 2012 Dec; 19(12):1664-7. PubMed ID: 23036171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.
    Kleyweg RP; van der Meché FG
    J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):957-60. PubMed ID: 1800666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
    van der Meché FG; Schmitz PI
    N Engl J Med; 1992 Apr; 326(17):1123-9. PubMed ID: 1552913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over IVIg in patients with axonal involvement.
    Dada MA; Kaplan AA
    Ther Apher Dial; 2004 Oct; 8(5):409-12. PubMed ID: 15663537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of Guillain-Barré syndrome treated with plasma exchange and intravenous high-dose immune globulin].
    Imai N; Miyata K; Terayama Y; Ishihara N
    Rinsho Shinkeigaku; 1997 Jun; 37(6):520-2. PubMed ID: 9366182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Guillain-Barré syndrome in aged patients: the effect of plasmapheresis.
    Yamashita S; Morinaga T; Matsumoto K; Sakamoto T; Kaku N; Matsukura S
    Intern Med; 1992 Nov; 31(11):1313-6. PubMed ID: 1295631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome in childhood: natural course and efficacy of plasmapheresis.
    Jansen PW; Perkin RM; Ashwal S
    Pediatr Neurol; 1993; 9(1):16-20. PubMed ID: 8452594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.